Literature DB >> 3820094

Generalizations in linear pharmacokinetics using properties of certain classes of residence time distributions. I. Log-convex drug disposition curves.

M Weiss.   

Abstract

Introducing the phenomenological concept of a time-varying fractional rate of elimination kD(t) and applying the theory of lifetime distributions, implications of the log-convexity of drug disposition curves are examined and some important applications are described. Linear pharmacokinetic systems exhibiting a log-convex impulse response and satisfying the basic conditions underlying the noncompartmental approach have the following properties: (1) The time-varying volume of distribution V(t) increases, and consequently the fractional rate of elimination kD(t) = CL/V(t) decreases monotonically. (2) The concentration-time curve and the time course of total amount of drug in the body, respectively, have an exponential tail [where V(t) approaches the equilibrium value VZ]. The relative dispersion of residence times (CV2D = VDRT/MDRT2) and the ratio Vss/VZ (Vss is the volume of distribution at steady state) act as measures of departure from pure monoexponential decay (one-compartment behaviour). The role of the latter parameters as shape parameters of the curve that characterize the distributional properties of drugs is discussed. Upper and lower bounds of the time course of drug amount in the body are derived using the parameters MDRT and CV2D or lambda Z (terminal exponential coefficient), respectively. This approach is also employed to construct upper bounds on the fractional error in AUC determination by numerical integration that is due to curve truncation. The significance of the fractional elimination rate concept as a unifying approach in interspecies pharmacokinetic scaling is pointed out. Some applications of the results are demonstrated, using digoxin data from the literature.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3820094     DOI: 10.1007/bf01067968

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  23 in total

Review 1.  Kinetic analysis of turnover data.

Authors:  M Berman
Journal:  Prog Biochem Pharmacol       Date:  1979

2.  Pharmacokinetics of digoxin: relationship between response intensity and predicted compartmental drug levels in man.

Authors:  W G Kramer; A J Kolibash; R P Lewis; M S Bathala; J A Visconti; R H Reuning
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

3.  Importance of tissue distribution in determining drug disposition curves.

Authors:  M Weiss
Journal:  J Theor Biol       Date:  1983-08-21       Impact factor: 2.691

4.  Model-independent assessment of accumulation kinetics based on moments of drug disposition curves.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  A note on the rôle of generalized inverse Gaussian distributions of circulatory transit times in pharmacokinetics.

Authors:  M Weiss
Journal:  J Math Biol       Date:  1984       Impact factor: 2.259

6.  Amiodarone disposition: polyexponential, power and gamma functions.

Authors:  G T Tucker; P R Jackson; G C Storey; D W Holt
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  On some stochastic formulations and related statistical moments of pharmacokinetic models.

Authors:  J H Matis; T E Wehrly; C M Metzler
Journal:  J Pharmacokinet Biopharm       Date:  1983-02

8.  Hemodynamic influences upon the variance of disposition residence time distribution of drugs.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1983-02

9.  A model independent approach to describe the blood disappearance profile of intravenously administered drugs.

Authors:  K Takada; S Asada
Journal:  Chem Pharm Bull (Tokyo)       Date:  1981-05       Impact factor: 1.645

10.  Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.

Authors:  H Boxenbaum
Journal:  J Pharmacokinet Biopharm       Date:  1982-04
View more
  13 in total

1.  Does the dose-solubility ratio affect the mean dissolution time of drugs?

Authors:  P Lánský; M Weiss
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

2.  Cellular pharmacokinetics: effects of cytoplasmic diffusion and binding on organ transit time distribution.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1999-06

3.  The anomalous pharmacokinetics of amiodarone explained by nonexponential tissue trapping.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

4.  Dynamics of drug distribution. I. Role of the second and third curve moments.

Authors:  M Weiss; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1992-06

5.  The relevance of residence time theory to pharmacokinetics.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 6.  Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).

Authors:  P Veng-Pedersen
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

7.  Residence time dispersion as a general measure of drug distribution kinetics: estimation and physiological interpretation.

Authors:  Michael Weiss
Journal:  Pharm Res       Date:  2007-05-18       Impact factor: 4.200

8.  Exponential tails of drug disposition curves: reality or appearance?

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-12-13       Impact factor: 2.745

9.  A novel extravascular input function for the assessment of drug absorption in bioavailability studies.

Authors:  M Weiss
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

10.  Tissue distribution kinetics as determinant of transit time dispersion of drugs in organs: application of a stochastic model to the rat hindlimb.

Authors:  M Weiss; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1996-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.